Advertisement

Physician's First Watch Archive

Medical news from NEJM Journal Watch

May 28, 2015

By Kelly Young

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM

Perioperative beta-blockade in patients undergoing noncardiac surgery is associated with reduced mortality only in those with three or more risk factors, …

By the Editors

NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:

NEJM Clinical Practice Center: Case Record: A …

By the Editors

Early treatment for patients with HIV is associated with over a 50% reduction in risk for serious illness or death, according to study data released by the National Institute of Allergy and …

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM

Most of the 100-plus genes commonly included in gene panel tests have no known link to breast cancer, researchers argue in the New England Journal of Medicine.

They note that such …

By Kristin J. Kelley

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM

The FDA has approved a once-daily inhalation spray (marketed as Stiolto Respimat) for …

May 27, 2015

By Amy Orciari Herman

Edited by Lorenzo Di Francesco, MD, FACP, FHM

A new study in BMJ adds to the evidence showing increased venous thromboembolism (VTE) risk with newer versus older combination oral contraceptives.

Using two U.K. …

By Amy Orciari Herman

Edited by Lorenzo Di Francesco, MD, FACP, FHM

Delayed umbilical cord clamping is associated with better fine motor and social skills at preschool age, at least among boys, a JAMA Pediatrics study finds.

Researchers studied some 250 children …

By Kelly Young

Edited by Lorenzo Di Francesco, MD, FACP, FHM

A person traveling to the U.S. from Liberia has died from Lassa fever, a viral hemorrhagic disease, the CDC reports.

On May 17, the man arrived …

By Larry Husten

Edited by Lorenzo Di Francesco, MD, FACP, FHM

With no established differences in health outcomes, the relative success of two highly anticipated cholesterol drugs will likely depend on convenience, dosing, and price, Reuters reports. …

Pages